340 related articles for article (PubMed ID: 19260522)
1. Characteristics of gastric and intestinal mucin phenotypes of gastric carcinoma.
Mabuchi N; Niwa Y; Hirooka Y; Ohmiya N; Itoh A; Maeda O; Ando T; Goto H
Hepatogastroenterology; 2008; 55(88):2277-81. PubMed ID: 19260522
[TBL] [Abstract][Full Text] [Related]
2. Absence of either gastric or intestinal phenotype in microscopic differentiated gastric carcinomas.
Kawachi H; Takizawa T; Eishi Y; Shimizu S; Kumagai J; Funata N; Koike M
J Pathol; 2003 Apr; 199(4):436-46. PubMed ID: 12635134
[TBL] [Abstract][Full Text] [Related]
3. Re-evaluation of mucin phenotypes of gastric minute well-differentiated-type adenocarcinomas using a series of HGM, MUC5AC, MUC6, M-GGMC, MUC2 and CD10 stains.
Shiroshita H; Watanabe H; Ajioka Y; Watanabe G; Nishikura K; Kitano S
Pathol Int; 2004 May; 54(5):311-21. PubMed ID: 15086835
[TBL] [Abstract][Full Text] [Related]
4. Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
Sasaki A; Kitadai Y; Ito M; Tanaka S; Yoshihara M; Haruma K; Chayama K
Oncology; 2004; 66(5):379-87. PubMed ID: 15331925
[TBL] [Abstract][Full Text] [Related]
5. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
6. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
7. Unclassified mucin phenotype of gastric adenocarcinoma exhibits the highest invasiveness.
Han HS; Lee SY; Lee KY; Hong SN; Kim JH; Sung IK; Park HS; Jin CJ; Min YI
J Gastroenterol Hepatol; 2009 Apr; 24(4):658-66. PubMed ID: 19175827
[TBL] [Abstract][Full Text] [Related]
8. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.
Sasaki I; Yao T; Nawata H; Tsuneyoshi M
Cancer; 1999 Apr; 85(8):1719-29. PubMed ID: 10223565
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining for P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha may complement mucin phenotype of differentiated-type early gastric carcinoma.
Takano K; Hasegawa G; Jiang S; Kurosaki I; Hatakeyama K; Iwanari H; Tanaka T; Hamakubo T; Kodama T; Naito M
Pathol Int; 2009 Jul; 59(7):462-70. PubMed ID: 19563409
[TBL] [Abstract][Full Text] [Related]
10. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
11. The clinical meaning of mucin phenotype and Epstein-Barr virus infection in gastric cancer.
Nakamura Y; Yanai H; Kitoh T; Matsubara Y; Hirano A; Okamoto T; Yoshida T; Nishikawa J; Okita K
Hepatogastroenterology; 2008; 55(81):41-5. PubMed ID: 18507075
[TBL] [Abstract][Full Text] [Related]
12. Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype.
Shibata N; Watari J; Fujiya M; Tanno S; Saitoh Y; Kohgo Y
Hum Pathol; 2003 Jan; 34(1):32-40. PubMed ID: 12605364
[TBL] [Abstract][Full Text] [Related]
13. [Down-regulation of caveolin-1 in gastric carcinoma and its clinical biological significance].
Gao X; Sun Y; Huang L; Chen XY; Zhang KL; Kong QY; Liu J; Li H
Ai Zheng; 2005 Mar; 24(3):311-6. PubMed ID: 15757532
[TBL] [Abstract][Full Text] [Related]
14. Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer.
Yamagishi M; Noda M; Tatsumi Y; Mukaisho K; Mitsufuji S; Sugihara H; Okanoue T; Hattori T
J Gastroenterol; 2004 Dec; 39(12):1143-9. PubMed ID: 15622477
[TBL] [Abstract][Full Text] [Related]
15. Loss of phenotypic expression is related to tumour progression in early gastric differentiated adenocarcinoma.
Nakamura T; Yao T; Kabashima A; Nishiyama K; Maehara Y; Tsuneyoshi M
Histopathology; 2005 Oct; 47(4):357-67. PubMed ID: 16178890
[TBL] [Abstract][Full Text] [Related]
16. Expression of MUC2 in gastric carcinomas and background mucosae.
Lee HW; Yang DH; Kim HK; Lee BH; Choi KC; Choi YH; Park YE
J Gastroenterol Hepatol; 2007 Aug; 22(8):1336-43. PubMed ID: 17559374
[TBL] [Abstract][Full Text] [Related]
17. Intestinal metaplasia and gastric carcinoma. A histochemical and immunohistochemical study.
Jiang YQ; Du XX; Guo SY; Ma Z
Chin Med J (Engl); 1990 Oct; 103(10):821-5. PubMed ID: 2125255
[TBL] [Abstract][Full Text] [Related]
18. [Aberrant expression of MUC2 and MUC3 genes in gastric carcinoma and its significance].
Wang R; Fang D; Liu W; Luo Y
Chin Med J (Engl); 2000 Jun; 113(6):502-7. PubMed ID: 11775866
[TBL] [Abstract][Full Text] [Related]
19. Different characteristics of carcinoma in the gastric remnant: histochemical and immunohistochemical studies.
Matsui N; Yao T; Akazawa K; Nawata H; Tsuneyoshi M
Oncol Rep; 2001; 8(1):17-26. PubMed ID: 11115563
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
Lee OJ; Kim HJ; Kim JR; Watanabe H
Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
